With intravenous infusion of doubly-labeled [ 2 H 3 C-1-13 C-] methionine and stable isotope enrichments in plasma free methionine and carbon dioxide in breath air, whole body transmethylation, transsulfuration, and remethylation rates can be calculated. This technique demonstrated impaired recycling as the major disturbance to explain hyperhomocysteinemia in patients with end-stage renal failure, and can be used to optimize interventions with folate, B 6 , and B 12 supplementation in this patient group. Intravenous infusion of [2, 3, H 3 ] serine has also been applied to demonstrate the appearance of [ 2 H 2 ]-as well as [ 2 H 1 ]-methionine in plasma and protein, suggesting transfer of a one-carbon group from serine via 5,10-methylenetetrahydrofolate in human hepatocyte cytosol and mitochondria, respectively. In sheep, tissue free methionine enrichments after infusion of universally labeled [U-13 C] methionine showed the highest remethylation activity in postmortem investigation of jejunum, liver, and kidney tissue samples, but no such activity in muscle and brain samples. Methods to quantitate one-carbon acceptor metabolism pathways and folate metabolism have recently become available.
Introduction
Methionine is an essential sulfer-containing amino acid which is derived from ingested protein. It can also be formed by recycling its metabolic product, homocysteine, in a metabolic cycle which involves the transmethylation pathway (three enzymatic steps via S-adenosyl methionine) and the remethylation of homocysteine (two enzymatic steps). Together with serine, methionine is a major donor of one-carbon (methyl) units for methyl acceptor reactions which involve, among others, arginine, phospholipid, glutathione synthesis, and biosynthesis (nucleotide formation and DNA methylation).
In the breakdown of homocysteine in the transsulfuration pathway, the carbon skeleton of methionine can be degraded into, ultimately, α-ketobutyrate which is a fuel for the tricarbocyl cycle. Serine is required in this reaction which results in the incorporation of the sulfer atom of homocysteine into a newly formed cysteine molecule.
The B vitamins folate, pyridoxin (B 6 ), and cobalamin (B 12 ) are closely connected with the metabolism of methionine and serine in a number of ways ( fig. 1 ). Vitamin B 6 is a cofactor in the transsulfuration pathway for the enzyme cystathionine β synthase and is also a cofactor for serine hydroxymethyltransferase, which generates 5,10-methylene tetrahydrofolate from tetrahydrofolate. Folate coenzymes serve as acceptors or donors of one-carbon units in a variety of reactions. The enzyme 5,10-methylene tetrahydrofolate reductase is the regulating enzyme in the remethylation pathway, where vitamin B 12 is a cofactor for the enzyme methionine synthase. The tetrahydro derivatives of folate are cofactors for several (acceptor) methyl transferase reactions.
One carbon metabolism in humans, and in particular the interrelationships among folate and vitamin B 12, as well as those of methionine, homocysteine, and vitamin B 6 have gained the interest of scientists since the discoveries of their roles in macrocytic megaloblastic anemia and the vascular complications in patients with cystathionine β synthase deficiency, respectively. In recent years, folate supplementation has received attention because of its preventive effect in relation to neural tube defects and other congenital malforma-114 tions. Reduced vitamin B 12 status and elevated blood homocysteine levels (denoted hyperhomocysteinemia) have been associated with birth defects as well, and also with adverse pregnancy outcome. All women in their reproductive years should increase their folate intake above their regular intake with at least 400 µg per day [1] . In the United States, folic acid has been added to grain products since January 1, 1998. It has been calculated that this raises the adult intake by about 100 µg per day, and reduced the incidence of neural tube defects by 19% [2] . Hyperhomocysteinemia has emerged as a prevalent risk factor for atheroslerotic vascular disease in the coronary, cerebral and peripheral blood vessels and thrombotic events [3] . Genetic polymorphisms in methylenetetrahydrofolate reductase constitute a risk factor for hyperhomocysteinemia and pregnancy complicated by neural tube defects. Apart from mortality due to cardiovascular events, hyperhomocystenemia has also been associated with elevated total mortality in patients with diabetes mellitus and in the general population [4] . Supplementation with B vitamins, in particular with folate, is efficient and effective in reducing an elevated homocysteine level in the blood [5] . The clinical and epidemiological endpoints of B vitamin supplementation are the subject of ongoing trials.
Genetic studies and assessment of vitamin status have, in addition to measurements of the blood levels of sulfur-containing amino acids, revealed many key aspects of the role of methionine and its metabolic associates in humans. Clinical studies in patients with cystathionine β synthase deficiency and in patients with end-stage renal disease, in whom hyperhomocysteinemia has a high prevalence, have also provided insights into the pathophysiology of sulfer-containing amino acids and the efficacy of interventions. However, although many associations have been demonstrated and single enzyme characteristics and mutations are well studied, their impact on elucidating the biology and physiology of one-carbon unit metabolism remains largely unknown. This hampers the possibility of educating the population with respect to B vitamin intake and bodily functions and also requires large and costly intervention studies to determine the optimal dosage for vitamin combinations with respect to interindividual phenotypical and genotypical variations.
Stable isotope tracer studies are safe and provide information of the flux rates in metabolic pathways. Many applications in nutritional and micronutrient studies have been developed.
Tracer methodology: methionine and onecarbon metabolism
In the mammalian body, the complexity of methionine metabolism (depicted in fig. 1 ) would require the study of tissues and organs as well as their contributions to the condition of the whole organism. In humans, the limitations with regard to obtaining tissue samples are obvious. Apart from minimal invasive methods applicable to humans, an invasive procedure will also be discussed which can be used in animal studies. Alternatively, methionine tracers can be used for noninvasive measurement of tissue protein synthesis and the use of metaprobes in homocysteine metabolism will also be discussed. The overview is summarized in table 1. 13 C] methionine has stable isotope tracers on its methyl group (m+3) and on the carbon skeleton (m+1). This tracer allows the measurement of methionine transmethylation, remethylation, and transulfuration and corrects for exchange with body protein pools [6] . The method has a solid background because the study protocol resembles that of other essential amino acid tracers such as [ 13 C] leucine and [ 13 C] valine. In the fasting condition, a primed, continuous intravenous infusion of doubly-labeled [ 2 H 3 C-1-13 C-] methionine is given, and plateaus in stable isotope enrichments in plasma-free methionine and carbon dioxide in breath air are obtained after 4 to 6 hours. Validity with respect to the use of methionine as a precursor of homocysteine has been addressed [9] . The method can be applied to study (patho)physiology and interventions on homocysteine metabolism, as shown below.
Whole body methionine fluxes
[ 2 H 3 C-1-
Whole body serine fluxes
[2,3,3-2 H 3 ] serine (m+3) donates one deuterium to glycine in its conversion by both cytosolic and mitochondrial serine hydroxymethyltransferases, and the resulting [5,10-C 2 H 2] ] tetrahydrofolate molecule loses another deuterium atom by the action of methyltetrahydrofolate dehydrogenase which is present in mitochondria but not in the cytosol. Gregory et al. discovered that these two subcellular pathways are present in a primed, continuous infusion protocol in one fasting adult [7] . This conclusion became apparent when they found 2 H 1 and 2 H 2 methionine isotopomers in the blood. 2 H 1 serine was the predominant form of labeled serine (m+1) in apolipoprotein-B100 (a liver derived protein), which shows the highly active state of hepatic serine undergoing catalytic cleavage into glycine. However, no detectable labeling in glycine was found. The presence of m+3 cystathionine resulted from the reaction of homocysteine with serine m+3 catalyzed by cystathionine β-synthase, the rate limiting step in the transulfuration pathway. This stable isotope approach demonstrates the usefulness of tracers in the study of cellular metabolism. 
Tissue methionine metabolism
Universally labeled [U- 13 C] methionine (m+5) can be obtained from an amino acid mixture produced from hydrolyzed algae protein. This tracer has been applied in a study in sheep, who were randomized to study the effect of choline plus creatine on methionine metabolism [8] . The protocol involved infusions on days 5 and 8 with either the aforementioned tracer or a combination of [ 2 H 3 C] methionine (m+3) and [1-13 C] methionine (m+1), and sampling of blood and tissues after termination of the animal. Because methionine has five carbons, the enrichment of the [U-13 C] labeled molecule represents the total methionine turnover. The m+4 enrichment represents the remethylation rate, because the transmethylation reaction converts methionine m+5 into homocysteine m +4, which is reconverted into methionine m+4 by the enzyme methionine synthase which catalyzes the replacement of an unlabeled methyl carbon moiety. In this study procol, remethylation cannot be measured with the m+3 and m+1 tracers because the remethylated tracer molecules (with mass m and m+1, respectively) enter the methionine pools which are diluted by methionine from protein breakdown. From comparisons of methionine enrichment in plasma obtained from the aorta, and portal and hepatic veins, Lobley et al. concluded that the viscera and liver were the major sites of remethylation [8] . This was confirmed by enrichment analyses in tissue free methionine, which showed the highest remethylation rates in rumen, jejunum, and liver and a lower contribution in kidney but no substantial remethylation in skeletal and heart muscle, skin, and lung. Remethylation calculated from plasma enrichement was not significantly changed during choline plus creatinine supplementation in this ruminant model.
Tracing homocysteine metabolism-13 C-homocysteine
[1-13 C] homocysteine would appear to be an attractive candidate tracer for homocysteine clearance studies. Its derivatization and mass spectrometry procedures for measuring enrichment in plasma are feasible [8] .
In theory, a 13 C stable isotope tracer introduced in the transsulfuration pathway may be used to assess its activity in a noninvasive way by measuring 13 CO 2 enrichments in exhaled breath samples. This would seem to provide more accurate pathophysiological data in subjects with elevated homocysteine levels than the methionine loading test which is presently used but which involves superphysiological doses of methionine in order to be able to raise the homocysteine concentration in susceptible patients. Use of 13 C-homocysteine as a tracer is hampered by its availability and (as yet unsubstantiated) concerns that its infusion may cause local reactions in the canulated effluent peripheral blood vessels.
Tracing homocysteine metabolism: homocysteine metaprobe
Use of a metabolic probe (an isotopically labeled precursor probe that is converted to a labeled product by the action of the enzyme or process of interest, also coined as metaprobes) which is metabolized to homocysteine would provide an alternative. Such a probe, using oxoprolinase to convert the metaprobe (labeled 2-oxo-thiazine-4-carboxylic acid) into a labeled homocysteine homologue, has been developed and studied in rats [10] . Studies in humans would require safety tests of the metaprobe.
Tracing protein synthesis: positron emission tomography (PET) scanning
A radioactive [H 3 11 C-] methionine tracer has been used for the noninvasive measurement with PET scanning of mixed protein synthesis in skeletal muscle in adults [11] . It has the advantage of not requiring muscle or blood samples. This method can theoretically also be used to follow protein catabolism, by continuous measuring after stopping the label infusion. Its disadvantages are radiation dose, and costs of the label and PET scanning. Any essential amino acid labeled with 11 C could be used for the same purpose, and this particular method thus is not confined to the use of methioinine. The use of PET scanning using labeled methionine or serine tracers in the elucidation of regional organ metabolism of one-carbon donors, e.g., in the central nervous system, awaits further exploration.
Tracer methodology: one-carbon acceptor metabolism
Interrelations between the one-carbon donor pathways and methyl transferase acceptor pathways are pivotal for the understanding of one-carbon metabolism. Methionine transmethylation is a primary contributor to the acceptor reactions, and 5-methyltetrahydrofolate is another important donor. Serine conversion into glycine is another quantitatively important route, resulting in the formation of 5,10-methylene tetrahydrofolate and, via methylenetetrahydrofolate reductase, in 5-methyltetrahydrofolate. The relative contributions of carbon precursors from food, and the buffering effect of the intracellular folate co-enzyme pools have not yet been studied in vivo. Tracer methods for methionine and serine, such as those discussed above, could be applied for that purpose. Development of methods to measure and trace enrichments in the methyl and formyl moiety of folate is pending.
Interests can be focused on the quantification and regulation of methyl acceptor pathways, including those involved in arginine and nitrous oxide production, glutathion and creatine synthesis, phospholipid synthesis and cell replication (nucleotide synthesis and DNA-methylation). Minimal-and noninvasive stable isotope methods are available for the quantification of these processes and include tracer technology and, in the case of creatine metabolism, 1 H and 31 P magnetic resonance spectroscopy. These methods are summarized in table 2.
B-group vitamin interactions: labeled folates
Deuterium and carbon labeled folic acid have been used to study folate absorption and cellular retention in a variety of clinical protocols, using 24 or 48 hour urinary excretion ratios of oral and intravenous doses, or short-term enrichment in plasma folate as measurement [19, 20] . Isotopically labeled folates, especially [6S]-5CH 3 H 4 PteGlu (natural l-isomer), have been commercially available since 2000 (Eprova AG, Schaffhausen, Switzerland). Rapid measurement will be facilitated with the combined development of liquid chromatography-tandem mass spectrometry to measure enrichments in 5-methyltetrahydrofolate and other folates involved in 1-carbon metabolism in small plasma samples, as shown elsewhere in this supplement [21] , and kinetic modeling techniques.
Pathophysiology of hyperhomocysteinemia in patients with end-stage renal disease
Hyperhomocysteinemia is reported in 85% to 100% of patients with end-stage renal disease (ESRD), and elevated plasma homocysteine levels have been shown to be an independent risk factor for cardiovascular disease not only in the general population but also in ESRD patients [22, 23] . It has been indicated that the functional loss of the kidney to clear homocysteine is the putative pathophysiological factor to explain hyperhomocysteinemia in ESRD patients [24] , but this explanation has been questioned [25] . Studies in rodents showed that normal rats and those with hyperhomocysteinemia have a significantly lower concentration of homocysteine in the renal vein than in the artery, and transsulfuration activity in the rat renal tubule has been held responsible for this finding [24, 26] . These experiments support the hypothesis that loss of kidney function results directly in inability to clear homocysteine. However, in fasting humans with normal renal function who underwent catheterization no significant net renal uptake of homocysteine was found, suggesting that, contrary to the findings in rodents, loss of such uptake cannot cause hyperhomocysteinemia in humans [27] . Studies with [ 2 H 3 C-1-13 C] methionine showed that in patients with ESRD as compared with healthy humans remethylation and transmethylation rates were markedly (up to 27%) and significantly decreased [28] . Although transsulfuration was 17% lower in the patients with ESRD in that study, the difference was not statistically significant. This may have been due to an insufficient statistical power in that study.* Preliminary findings, published in abstract form, suggested that supplementation with folic acid (5 mg/day during three weeks) significantly improves the remethylation and transmethylation rates in the ESRD patients, but does not result in mean rates comparable to those of healthy controls.** We are presently using this stable isotope method for studying the effects of In vivo stable isotope measurements of methyl metabolism vitamins B 6 and B 12 in relation to transulphuration and folate and B 12 in relation to remethylation. It can also be used to evaluate the effects of pharmacological interventions affecting homocysteine metabolism. As a result of the lower coefficients of variation for the methylation flux rates than for plasma homocysteine, and because the effects on specific pathways can be distinguished, such intervention studies can be done with a much smaller group size without loss of power when stable isotope methods are used than when homocysteine blood levels are used as the end-point.
Conclusions
Methionine and one-carbon metabolism, and their interactions with B vitamins, take place at different rates in the tissues and contribute to the effects observed at whole body levels, e.g. in patients with elevated blood homocysteine levels. The physiol-ogy and pathophysiology in humans can be further studied using several stable isotope methods. Methods have been developed, many of these recently, to study transmethylation, remethylation, and transsulfuration fluxes, folate absorption and retention, and one-carbon acceptor reactions in a quantitative way. There are emerging possibilities to study interactions between vitamins and these metabolic pathways. These in vivo isotope techniques are available for various studies of pathophysiology and interventions in methyl group transfer involving folate, vitamin B 6 , vitamin B 12 , and pharmacological and food derived substances.
